Embarc

BioEclipse Therapeutics, Inc.

https://www.bioeclipse.com/
State Juristiction
DE
Date of Incorporation
2006-05-26
CIK
1780708
Legal Form
Corporation
Offering via NetCapital Funding Portal Inc.
  • As of 2022-01-19, raising $10,001.10-$1,069,997.85 via 3,922+ of Common Stock at $2.55 by 2022-03-01Costing 5% in cash and 0% in equity
  • As of 2022-02-28, raising $10,001.10-$1,069,997.85 via 3,922+ of Common Stock at $2.55 by 2022-04-01Costing 5% in cash and 0% in equity
  • As of 2022-04-01, raising $10,001.10-$1,069,997.85 via 3,922+ of Common Stock at $2.55 by 2022-04-19Costing 5% in cash and 0% in equity
Filing date2022-01-19
Current employees5
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$2,331,499.00
Cash equi prior fiscal year$5,394,836.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$4,391,188.00
Net income prior fiscal year-$2,415,736.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$75,862.00
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$2,956,073.00
Total asset prior fiscal year$5,839,337.00